Details for Patent: 11,497,753

Which drugs does patent 11,497,753 protect, and when does it expire?

Patent 11,497,753 protects OTREXUP and XYOSTED (AUTOINJECTOR) and is included in two NDAs.

This patent has fourteen patent family members in eight countries.

Summary for Patent: 11,497,753

Title:	Hazardous agent injection system
Abstract:	Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
Inventor(s):	Paul K. WOTTON, Peter L. Sadowski, John W. Hayes
Assignee:	Antares Pharma Inc
Application Number:	US16/715,781
Patent Claim Types: see list of patent claims	Use; Compound; Delivery; Device; Dosage form;

Drugs Protected by US Patent 11,497,753

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Cosette	OTREXUP	methotrexate	SOLUTION;SUBCUTANEOUS	204824-005	Nov 7, 2014		DISCN	Yes	No	11,497,753		Y
Cosette	OTREXUP	methotrexate	SOLUTION;SUBCUTANEOUS	204824-001	Oct 11, 2013		DISCN	Yes	No	11,497,753		Y
Cosette	OTREXUP	methotrexate	SOLUTION;SUBCUTANEOUS	204824-006	Mar 24, 2016		DISCN	Yes	No	11,497,753		Y
Cosette	OTREXUP	methotrexate	SOLUTION;SUBCUTANEOUS	204824-002	Oct 11, 2013		DISCN	Yes	No	11,497,753		Y
Cosette	OTREXUP	methotrexate	SOLUTION;SUBCUTANEOUS	204824-007	Mar 24, 2016		DISCN	Yes	No	11,497,753		Y

International Family Members for US Patent 11,497,753

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2010226442
Canada	2755779
China	102612381
European Patent Office	2408493
European Patent Office	4427737